Literature DB >> 18939910

Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory support.

Sanjeev Aggarwal1, Mark S Slaughter.   

Abstract

Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is the leading cause of in-hospital death for patients admitted with acute coronary syndromes. Expert guidelines for the care of AMI-CS patients recommend early revascularization with intra-aortic balloon pump support. Ventricular assist devices (VADs) offer the advantages of providing greater and longer-term cardiac support than an intra-aortic balloon pump and may improve outcomes when inserted early after heart failure symptoms begin. Pulsatile VADs are versatile and can provide biventricular support but are associated with a higher incidence of serious complications. The newer percutaneous VADs can normalize cardiac index and can be implanted without surgery. Therefore, early implementation of percutaneous VADs and early revascularization may reduce the high mortality of AMI-CS. However, access to revascularization and VAD support, including percutaneous VADs, is currently limited and must improve to more effectively treat AMI-CS patients.

Entities:  

Mesh:

Year:  2008        PMID: 18939910     DOI: 10.1586/14779072.6.9.1223

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Short-term mechanical management of cardiogenic shock.

Authors:  Jessica L Brown; Roberta C Bogaev; Jack O'Connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-08

Review 2.  Management of Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.

Authors:  Steven P Keller
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

3.  Percutaneous cardiac support during myocardial infarction drastically reduces mortality: perspectives from a swine model.

Authors:  Maria Giovanna Trivella; Alessandra Piersigilli; Fabio Bernini; Gualtiero Pelosi; Silvia Burchielli; Stefano Puzzuoli; Claudia Kusmic; Antonio L'Abbate
Journal:  Int J Artif Organs       Date:  2017-06-06       Impact factor: 1.595

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.